Log in to search using one of your social media accounts:


Bellerophon Therapeutics misses EPS estimates in Q3

Shares in Bellerophon Therapeutics (NSDQ:BLPH) fell slightly today after the company missed EPS expectations on Wall Street with its third quarter results. The Warren, N.J.-based company posted a net loss of -$7.6 million for the 3 months ended Sept. 30, for bottom-line loss of -81% compared with the same period last year. Get the full story at our sister site, Drug Delivery Business News. The post Bellerophon Therapeutics misses EPS estimates in Q3 appeared first on MassDevice.
Source: Mass Device - Category: Medical Devices Authors: Tags: Drug-Device Combinations MassDevice Earnings Roundup Respiratory Vascular Wall Street Beat Bellerophon Therapeutics Source Type: news

Related Links:

More News: Profits and Losses | Respiratory Medicine